See other companies on Welcome to the Jungle

DeepMirror

AI-powered drug design software

DeepMirror logo
1-20 employees
  • Healthcare
  • B2B
  • Artificial Intelligence
  • Deep Tech
  • Biology
  • SaaS
  • Data Analysis
Covent Garden, London, UK

Company mission

Make AI powered drug design as simple as a spreadsheet to empower scientists across the globe.

Top investors

33% female employees

Our take

To help elevate biology for healthcare, DeepMirror is building a molecular drug design platform that leverages the power of generative AI to streamline the discovery of medically active molecules.

DeepMirror's AI is able to suggest realistic molecules, that could be synthesised without too much difficulty, and are both safe and active for medicinal use. Through the platform, scientists can also run custom predictions based on their own compounds and data, and rank and prioritise their synthetic targets.

Ultimately, these features have the potential to fast-track research and drug discovery, supporting better healthcare outcomes. As a spin-out of the University of Cambridge, DeepMirror benefits from a respected foundation, and has launched its Early Access Programme for the platform after a successful closed beta.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Benefits

  • Cycle Scheme
  • Frequent off-sites and other social events
  • Flexible working
  • Great Stash

Company values

  • GROWTH - We foster continuous learning, development, and we push our limits to drive innovation and professional development in a challenging environment. We have not arrived at our destination yet
  • INNOVATION - We strive to innovate and build things that have not been built before to empower the Life Sciences industry to do better. We prioritise meaningful work and societal contribution in everything we do
  • COMMUNITY - We cultivate a supportive, collaborative, and family-like team atmosphere. Individuals support each other and help each other grow
  • OWNERSHIP - We encourage independent decision-making and responsibility for one's work and outcomes. We are self-driven entrepreneurs, always on the initiative
  • OPENNESS - We value open, honest dialogue and diverse perspectives for effective teamwork and decision-making

Funding (1 round)

Sep 2021

$1.9m

SEED

Total funding: $1.9m

This company has top investors

Leadership

Royal Academy of Engineering Enterprise Fellow from 2022 to 2023. Previously a Postdoctoral Research Fellow at the University of Cambridge, and Research Student at Osaka University.

College Research Associate at St John's College, Cambridge. Has conducted Postdoctoral Research at the University of Cambridge and the MRC Laboratory for Molecular Cell Biology (LMCB) at UCL.

Former Software and Machine Learning Engineer at Outfield Technologies. Previously a Research Assistant at The University of Manchester, and Research Scientist at Medtrade Products Limited.

Endorsements

All

My opinions are valued (2)

Challenging work (1)

Autonomy (1)

Open and honest communication (1)

Team energy (1)